Your browser doesn't support javascript.
loading
Prognostic Value of Chest CT Findings at BOS Diagnosis in Lung Transplant Recipients.
Van Herck, Anke; Beeckmans, Hanne; Kerckhof, Pieterjan; Sacreas, Annelore; Bos, Saskia; Kaes, Janne; Vanstapel, Arno; Vanaudenaerde, Bart M; Van Slambrouck, Jan; Orlitová, Michaela; Jin, Xin; Ceulemans, Laurens J; Van Raemdonck, Dirk E; Neyrinck, Arne P; Godinas, Laurent; Dupont, Lieven J; Verleden, Geert M; Dubbeldam, Adriana; De Wever, Walter; Vos, Robin.
Affiliation
  • Van Herck A; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Beeckmans H; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Kerckhof P; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Sacreas A; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Bos S; Division of Lung Transplantation, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Kaes J; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Vanstapel A; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Vanaudenaerde BM; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Van Slambrouck J; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Orlitová M; Department of Thoracic Surgery, Leuven Transplant Center, University Hospitals Leuven, Leuven, Belgium.
  • Jin X; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Ceulemans LJ; Department of Thoracic Surgery, Leuven Transplant Center, University Hospitals Leuven, Leuven, Belgium.
  • Van Raemdonck DE; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Neyrinck AP; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Godinas L; Department of Thoracic Surgery, Leuven Transplant Center, University Hospitals Leuven, Leuven, Belgium.
  • Dupont LJ; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Verleden GM; Department of Thoracic Surgery, Leuven Transplant Center, University Hospitals Leuven, Leuven, Belgium.
  • Dubbeldam A; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
  • De Wever W; Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Leuven, Belgium.
  • Vos R; Department of Respiratory Diseases, Leuven Transplant Center, University Hospitals Leuven, Leuven, Belgium.
Transplantation ; 107(11): e292-e304, 2023 Nov 01.
Article in En | MEDLINE | ID: mdl-37870882
ABSTRACT

BACKGROUND:

Bronchiolitis obliterans syndrome (BOS) after lung transplantation is characterized by fibrotic small airway remodeling, recognizable on high-resolution computed tomography (HRCT). We studied the prognostic value of key HRCT features at BOS diagnosis after lung transplantation.

METHODS:

The presence and severity of bronchiectasis, mucous plugging, peribronchial thickening, parenchymal anomalies, and air trapping, summarized in a total severity score, were assessed using a simplified Brody II scoring system on HRCT at BOS diagnosis, in a cohort of 106 bilateral lung transplant recipients transplanted between January 2004 and January 2016. Obtained scores were subsequently evaluated regarding post-BOS graft survival, spirometric parameters, and preceding airway infections.

RESULTS:

A high total Brody II severity score at BOS diagnosis (P = 0.046) and high subscores for mucous plugging (P = 0.0018), peribronchial thickening (P = 0.0004), or parenchymal involvement (P = 0.0121) are related to worse graft survival. A high total Brody II score was associated with a shorter time to BOS onset (P = 0.0058), lower forced expiratory volume in 1 s (P = 0.0006) forced vital capacity (0.0418), more preceding airway infections (P = 0.004), specifically with Pseudomonas aeruginosa (P = 0.002), and increased airway inflammation (P = 0.032).

CONCLUSIONS:

HRCT findings at BOS diagnosis after lung transplantation provide additional information regarding its underlying pathophysiology and for future prognosis of graft survival.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Bronchiolitis Obliterans / Lung Transplantation / Bronchiolitis Obliterans Syndrome Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Bronchiolitis Obliterans / Lung Transplantation / Bronchiolitis Obliterans Syndrome Limits: Humans Language: En Year: 2023 Type: Article